Lymph node staging in colorectal cancer: Old controversies and recent advances

World Journal of Gastroenterology

Volumn 19, Issue 46, 2013, Pages 8515-8526

  Resch, Annika ^a   Langner, Cord ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Colon cancer; Extracapsular invasion; Immunohistochemistry; Lymph node metastasis; Lymph node ratio; Molecular analysis; Prognosis; Rectum cancer; Sentinel lymph node; Tumor staging

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CYTOKERATIN 19; CYTOKERATIN 20; K RAS PROTEIN; MUCIN 2; PROSTAGLANDIN E RECEPTOR 4; SCATTER FACTOR RECEPTOR; TRACER;

ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL EVALUATION; CLINICAL PRACTICE; COLORECTAL CANCER; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; META ANALYSIS (TOPIC); MICROMETASTASIS; OUTCOME ASSESSMENT; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY;

COLON CANCER; EXTRACAPSULAR INVASION; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MOLECULAR ANALYSIS; PROGNOSIS; RECTUM CANCER; SENTINEL LYMPH NODE; TUMOR STAGING;

COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM STAGING; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84890411622     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i46.8515     Document Type: Article

References (79)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30 [PMID: 23335087 DOI: 10.3322/caac.21166]
2. Washington MK. Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors. Arch Pathol Lab Med 2008; 132: 1600-1607 [PMID: 18834218]
3. Benson AB, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fleshman JW, Fuchs CS, Grem JL, Knol JA, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett C. Colon cancer. J Natl Compr Canc Netw 2011; 9: 1238-1290 [PMID: 22056656]
4. Benson AB, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fuchs CS, Grem JL, Hunt S, Leong LA, Lin E, Martin MG, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett CG, Freedman-Cass DA, Gregory KM. Rectal cancer. J Natl Compr Canc Netw 2012; 10: 1528-1564 [PMID: 23221790]
5. Nagtegaal ID, Tot T, Jayne DG, McShane P, Nihlberg A, Marshall HC, Påhlman L, Brown JM, Guillou PJ, Quirke P. Lymph nodes, tumor deposits, and TNM: are we getting better? J Clin Oncol 2011; 29: 2487-2492 [PMID: 21555695 DOI: 10.1200/JCO.2011.34.6429]
6. Sjo OH, Merok MA, Svindland A, Nesbakken A. Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 2012; 55: 307-315 [PMID: 22469798 DOI: 10.1097/DCR.0b013e3182423f62]
7. Akagi Y, Adachi Y, Kinugasa T, Oka Y, Mizobe T, Shirouzu K. Lymph node evaluation and survival in colorectal cancer: review of population-based, prospective studies. Anticancer Res 2013; 33: 2839-2847 [PMID: 23780968]
8. Wang LP, Wang HY, Cao R, Zhu C, Wu XZ. Proposal of a new classification for stage III colorectal cancer based on the number and ratio of metastatic lymph nodes. World J Surg 2013; 37: 1094-1102 [PMID: 23385643 DOI: 10.1007/ s00268013-1940-x]
9. Schiffmann L, Eiken AK, Gock M, Klar E. Is the lymph node ratio superior to the Union for International Cancer Control (UICC) TNM system in prognosis of colon cancer? World J Surg Oncol 2013; 11: 79 [PMID: 23521843 DOI: 10.1186/1477-7819-11-79]
10. Komuta K, Okudaira S, Haraguchi M, Furui J, Kanematsu T. Identification of extracapsular invasion of the metastatic lymph nodes as a useful prognostic sign in patients with resectable colorectal cancer. Dis Colon Rectum 2001; 44: 1838-1844 [PMID: 11742171]
11. Heide J, Krüll A, Berger J. Extracapsular spread of nodal metastasis as a prognostic factor in rectal cancer. Int J Radiat Oncol Biol Phys 2004; 58: 773-778 [PMID: 14967433]
12. Fujii T, Tabe Y, Yajima R, Yamaguchi S, Tsutsumi S, Asao T, Kuwano H. Extracapsular invasion as a risk factor for disease recurrence in colorectal cancer. World J Gastroenterol 2011; 17: 2003-2006 [PMID: 21528079 DOI: 10.3748/wjg.v17. i15.2003]
13. Fujii T, Tabe Y, Yajima R, Yamaguchi S, Tsutsumi S, Asao T, Kuwano H. Process of distant lymph node metastasis in colorectal carcinoma: implication of extracapsular invasion of lymph node metastasis. BMC Cancer 2011; 11: 216 [PMID: 21635742 DOI: 10.1186/1471-2407-11-216]
14. Rahbari NN, Bork U, Motschall E, Thorlund K, Büchler MW, Koch M, Weitz J. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 2012; 30: 60-70 [PMID: 22124103 DOI: 10.1200/JCO.2011.36.9504]
15. Nordgård O, Oltedal S, Kørner H, Aasprong OG, Tjensvoll K, Gilje B, Heikkilä R. Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach. Ann Surg 2009; 249: 602-607 [PMID: 19300229 DOI: 10.1097/SLA.0b013e31819ec923]
16. Vather R, Sammour T, Kahokehr A, Connolly A, Hill A. Quantitative lymph node evaluation as an independent marker of long-term prognosis in stage III rectal cancer. ANZ J Surg 2011; 81: 883-888 [PMID: 22507414 DOI: 10.1111/ j.1445-2197.2010.05595.x]
17. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, Editors. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2010
18. Puppa G, Sonzogni A, Colombari R, Pelosi G. TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Arch Pathol Lab Med 2010; 134: 837-852 [PMID: 20524862 DOI: 10.1043/1543-2165-134.6.837]
19. Sobin LH, Wittekind C, editors. International Union Against Cancer. TNM Classification of Malignant Tumors. 5th ed. New York: Wiley-Liss, 1997
20. Sobin LH, Wittekind C, editors. International Union Against Cancer. TNM Classification of Malignant Tumors. 6th ed. Hoboken: John Wiley & Sons, 2002
21. Sobin LH, Gospodarowicz MK, Wittekind C, editors. International Union Against Cancer. TNM Classification of Malignant Tumors. 7th ed. Oxford: Wiley-Blackwell, 2009
22. Rock JB, Washington MK, Adsay NV, Greenson JK, Montgomery EA, Robert ME, Yantiss RK, Lehman AM, Frankel WL. Debating Deposits: An Interobserver Variability Study of Lymph Nodes and Pericolonic Tumor Deposits in Colonic Adenocarcinoma. Arch Pathol Lab Med 2013; Epub ahead of print [PMID: 23902577]
23. Fielding LP, Arsenault PA, Chapuis PH, Dent O, Gathright B, Hardcastle JD, Hermanek P, Jass JR, Newland RC. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 1991; 6: 325-344 [PMID: 1912440]
24. Jass JR, O'Brien J, Riddell RH, Snover DC. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma: Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 2008; 129: 13-23 [PMID: 18089485]
25. Huh JW, Kim CH, Kim HR, Kim YJ. Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer. J Surg Oncol 2012; 105: 125-129 [PMID: 21837680 DOI: 10.1002/ jso.22072]
26. Bilimoria KY, Palis B, Stewart AK, Bentrem DJ, Freel AC, Sigurdson ER, Talamonti MS, Ko CY. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum 2008; 51: 154-161 [PMID: 18172729 DOI: 10.1007/ s10350-007-9114-2]
27. Gehoff A, Basten O, Sprenger T, Conradi LC, Bismarck C, Bandorski D, Merkelbach-Bruse S, Schneider-Stock R, Stoehr R, Wirtz RM, Kitz J, Müller A, Hartmann A, Becker H, Ghadimi BM, Liersch T, Rüschoff J. Optimal lymph node harvest in rectal cancer (UICC stages II and III) after preoperative 5-FU-based radiochemotherapy. Acetone compression is a new and highly efficient method. Am J Surg Pathol 2012; 36: 202-213 [PMID: 22251939 DOI: 10.1097/ PAS.0b013e31823fa35b]
28. Märkl B, Kerwel TG, Wagner T, Anthuber M, Arnholdt HM. Methylene blue injection into the rectal artery as a simple method to improve lymph node harvest in rectal cancer. Mod Pathol 2007; 20: 797-801 [PMID: 17483817]
29. Märkl B, Schaller T, Krammer I, Cacchi C, Arnholdt HM, Schenkirsch G, Kretsinger H, Anthuber M, Spatz H. Methylene blue-assisted lymph node dissection technique is not associated with an increased detection of lymph node metastases in colorectal cancer. Mod Pathol 2013; 26: 1246-1254 [PMID: 23599158 DOI: 10.1038/modpathol.2013.61]
30. Märkl B, Rößle J, Arnholdt HM, Schaller T, Krammer I, Cacchi C, Jähnig H, Schenkirsch G, Spatz H, Anthuber M. The clinical significance of lymph node size in colon cancer. Mod Pathol 2012; 25: 1413-1422 [PMID: 22684222 DOI: 10.1038/ modpathol.2012.92]
31. Basten O, Bandorski D, Bismarck C, Neumann K, Fisseler Eckhoff A. [Acetone compression. A fast, standardized method to investigate gastrointestinal lymph nodes]. Pathologe 2010; 31: 218-224 [PMID: 20012620 DOI: 10.1007/ s00292-009-1256-7]
32. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007; 99: 433-441 [PMID: 17374833]
33. Chen HH, Chakravarty K D, Wang JY, Changchien CR, Tang R. Pathological examination of 12 regional lymph nodes and long-term survival in stages I-III colon cancer patients: an analysis of 2,056 consecutive patients in two branches of same institution. Int J Colorectal Dis 2010; 25: 1333-1341 [PMID: 20676662 DOI: 10.1007/s00384-010-1020-8]
34. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006; 24: 3570-3575 [PMID: 16877723]
35. Norwood MG, Sutton AJ, West K, Sharpe DP, Hemingway D, Kelly MJ. Lymph node retrieval in colorectal cancer resection specimens: national standards are achievable, and low numbers are associated with reduced survival. Colorectal Dis 2010; 12: 304-309 [PMID: 19207700 DOI: 10.1111/ j.1463-1318.2009.01788.x]
36. Lykke J, Roikjaer O, Jess P. The relation between lymph node status and survival in Stage I-III colon cancer: results from a prospective nationwide cohort study. Colorectal Dis 2013; 15: 559-565 [PMID: 23061638 DOI: 10.1111/codi.12059]
37. Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, Perez de Arenaza D, Bonadeo FA. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum 2009; 52: 1244-1250 [PMID: 19571700]
38. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005; 23: 8706-8712 [PMID: 16314630]
39. Del Rio P, Dell'Abate P, Papadia C, Angeletta A, Montana C, Iapichino G, Sianesi M. Impact of lymph node ratio in the colorectal cancer staging system. Ann Ital Chir 2012; 83: 399-403; discussion 403-404 [PMID: 23064301]
40. Medani M, Kelly N, Samaha G, Duff G, Healy V, Mulcahy E, Condon E, Waldron D, Saunders J, Coffey JC. An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all. Int J Colorectal Dis 2013; 28: 1377-1384 [PMID: 23715847]
41. Tayyab M, Sharma A, Macdonald AW, Gunn J, Hartley JE, Monson JR. Prognostic significance of lymph node ratio in patients undergoing abdominoperineal resection of rectum. Langenbecks Arch Surg 2012; 397: 1053-1057 [PMID: 22875223 DOI: 10.1007/s00423-012-0986-9]
42. Thomas M, Biswas S, Mohamed F, Chandrakumaran K, Jha M, Wilson R. Dukes C colorectal cancer: is the metastatic lymph node ratio important? Int J Colorectal Dis 2012; 27: 309-317 [PMID: 22065110 DOI: 10.1007/s00384-011-13403]
43. Chen SL, Steele SR, Eberhardt J, Zhu K, Bilchik A, Stojadinovic A. Lymph node ratio as a quality and prognostic indicator in stage III colon cancer. Ann Surg 2011; 253: 82-87 [PMID: 21135690 DOI: 10.1097/SLA.0b013e3181ffa780]
44. Lu YJ, Lin PC, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Liang WY, Chen WS, Lin JK, Chang SC. The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg 2013; 37: 1927-1933 [PMID: 23609344 DOI: 10.1007/ s00268-0132051-4]
45. Kang J, Hur H, Min BS, Lee KY, Kim NK. Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation. J Surg Oncol 2011; 104: 53-58 [PMID: 21416471 DOI: 10.1002/jso.21913]
46. Wind J, Lagarde SM, Ten Kate FJ, Ubbink DT, Bemelman WA, van Lanschot JJ. A systematic review on the significance of extracapsular lymph node involvement in gastrointestinal malignancies. Eur J Surg Oncol 2007; 33: 401-408 [PMID: 17175130]
47. Lupattelli M, Maranzano E, Bellavita R, Tarducci R, Latini R, Castagnoli P, Bufalari A, Corgna E, Pinaglia D, Rossetti R, Ribacchi R, Latini P. Adjuvant radiochemotherapy in highrisk rectal cancer results of a prospective non-randomized study. Tumori 2001; 87: 239-247 [PMID: 11693802]
48. Al Sahaf O, Myers E, Jawad M, Browne TJ, Winter DC, Redmond HP. The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer. Dis Colon Rectum 2011; 54: 982-988 [PMID: 21730787 DOI: 10.1097/DCR.0b013e31821c4944]
49. Bembenek AE, Rosenberg R, Wagler E, Gretschel S, Sendler A, Siewert JR, Nährig J, Witzigmann H, Hauss J, Knorr C, Dimmler A, Gröne J, Buhr HJ, Haier J, Herbst H, Tepel J, Siphos B, Kleespies A, Koenigsrainer A, Stoecklein NH, Horstmann O, Grützmann R, Imdahl A, Svoboda D, Wittekind C, Schneider W, Wernecke KD, Schlag PM. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 2007; 245: 858-863 [PMID: 17522509]
50. Kitagawa Y, Ohgami M, Fujii H, Mukai M, Kubota T, Ando N, Watanabe M, Otani Y, Ozawa S, Hasegawa H, Furukawa T, Matsuda J, Kumai K, Ikeda T, Kubo A, Kitajima M. Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: a novel and minimally invasive approach. Ann Surg Oncol 2001; 8: 86S-89S [PMID: 11599910]
51. van der Zaag ES, Kooij N, van de Vijver MJ, Bemelman WA, Peters HM, Buskens CJ. Diagnosing occult tumour cells and their predictive value in sentinel nodes of histologically negative patients with colorectal cancer. Eur J Surg Oncol 2010; 36: 350-357 [PMID: 20163930 DOI: 10.1016/j.ejso.2009.11.008]
52. van der Zaag ES, Bouma WH, Tanis PJ, Ubbink DT, Bemelman WA, Buskens CJ. Systematic review of sentinel lymph node mapping procedure in colorectal cancer. Ann Surg Oncol 2012; 19: 3449-3459 [PMID: 22644513 DOI: 10.1245/ s10434-012-2417-0]
53. Saha S, Johnston G, Korant A, Shaik M, Kanaan M, Johnston R, Ganatra B, Kaushal S, Desai D, Mannam S. Aberrant drainage of sentinel lymph nodes in colon cancer and its impact on staging and extent of operation. Am J Surg 2013; 205: 302-305; discussion 302-305 [PMID: 23414953 DOI: 10.1016/ j.amjsurg.2012.10.029]
54. Retter SM, Herrmann G, Schiedeck TH. Clinical value of sentinel node mapping in carcinoma of the colon. Colorectal Dis 2011; 13: 855-859 [PMID: 20456461 DOI: 10.1111/ j.1463-1318.2010.02293.x]
55. Märkl B, Arnholdt HM, Jähnig H, Spatz H, Anthuber M, Oruzio DV, Kerwel TG. A new concept for the role of ex vivo sentinel lymph nodes in node-negative colorectal cancer. Ann Surg Oncol 2010; 17: 2647-2655 [PMID: 20333553 DOI: 10.1245/s10434-010-1030-3]
56. Hyslop T, Waldman SA. Molecular staging of node negative patients with colorectal cancer. J Cancer 2013; 4: 193-199 [PMID: 23459453 DOI: 10.7150/jca.5830]
57. Lotspeich E, Schoene M, Gerngross H, Schmidt R, Steinmann R, Ramadani M, Gansauge S. Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay. Langenbecks Arch Surg 2007; 392: 559-566 [PMID: 17457603]
58. Haince JF, Houde M, Beaudry G, L'espérance S, Garon G, Desaulniers M, Hafer LJ, Heald JI, Lyle S, Grossman SR, Têtu B, Sargent DJ, Fradet Y. Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodes. J Clin Pathol 2010; 63: 530-537 [PMID: 20498026 DOI: 10.1136/jcp.2009.072983]
59. Croner RS, Schellerer V, Demund H, Schildberg C, Papadopulos T, Naschberger E, Stürzl M, Matzel KE, Hohenberger W, Schlabrakowski A. One step nucleic acid amplification (OSNA) a new method for lymph node staging in colorectal carcinomas. J Transl Med 2010; 8: 83 [PMID: 20819209 DOI: 10.1186/1479-5876-8-83]
60. Iddings D, Ahmad A, Elashoff D, Bilchik A. The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol 2006; 13: 1386-1392 [PMID: 17009147]
61. Yamamoto H, Sekimoto M, Oya M, Yamamoto N, Konishi F, Sasaki J, Yamada S, Taniyama K, Tominaga H, Tsujimoto M, Akamatsu H, Yanagisawa A, Sakakura C, Kato Y, Matsuura N. OSNA-based novel molecular testing for lymph node metastases in colorectal cancer patients: results from a multicenter clinical performance study in Japan. Ann Surg Oncol 2011; 18: 1891-1898 [PMID: 21290195 DOI: 10.1245/ s10434-010-1539-5]
62. Koyanagi K, Bilchik AJ, Saha S, Turner RR, Wiese D, McCarter M, Shen P, Deacon L, Elashoff D, Hoon DS. Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res 2008; 14: 7391-7396 [PMID: 19010855 DOI: 10.1158/1078-0432.CCR-08-0290]
63. Ohlsson L, Hammarström ML, Israelsson A, Näslund L, Oberg A, Lindmark G, Hammarström S. Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RTPCR. Br J Cancer 2006; 95: 218-225 [PMID: 16755296]
64. Harbaum L, Pollheimer MJ, Kornprat P, Lindtner RA, Schlemmer A, Rehak P, Langner C. Keratin 20 a diagnostic and prognostic marker in colorectal cancer? Histol Histopathol 2012; 27: 347-356 [PMID: 22237712]
65. Nordgård O, Oltedal S, Kørner H, Aasprong OG, Tjensvoll K, Gilje B, Heikkilä R. The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RTPCR. Int J Colorectal Dis 2009; 24: 261-268 [PMID: 19119477 DOI: 10.1007/s00384-008-0613-y]
66. Conzelmann M, Dieterle CP, Linnemann U, Berger MR. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients. Int J Cancer 2003; 107: 617-628 [PMID: 14520701]
67. Lassmann S, Bauer M, Rosenberg R, Nekarda H, Soong R, Rüger R, Höfler H, Werner M. Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression. Int J Colorectal Dis 2004; 19: 87-94 [PMID: 13680284]
68. Bustin SA, Siddiqi S, Ahmed S, Hands R, Dorudi S. Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients. Int J Cancer 2004; 108: 412-417 [PMID: 14648708]
69. D'Armento G, Daniele L, Mariani S, Ottaviani D, Mussa A, Cassoni P, Sapino A, Bussolati G. Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer. Int J Surg Pathol 2009; 17: 93-98 [PMID: 19074466 DOI: 10.1177/10 66896908328574]
70. Bilchik AJ, Hoon DS, Saha S, Turner RR, Wiese D, DiNome M, Koyanagi K, McCarter M, Shen P, Iddings D, Chen SL, Gonzalez M, Elashoff D, Morton DL. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg 2007; 246: 568-75; discussion 575-7 [PMID: 17893493]
71. Oberg AN, Lindmark GE, Israelsson AC, Hammarström SG, Hammarström ML. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS. Int J Cancer 2004; 111: 101-110 [PMID: 15185350]
72. Ohlsson L, Israelsson A, Öberg Å, Palmqvist R, Stenlund H, Hammarström ML, Hammarström S, Lindmark G. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer. Int J Cancer 2012; 130: 1833-1843 [PMID: 21618511 DOI: 10.1002/ijc.26182]
73. Nordgård O, Oltedal S, Aasprong OG, Søreide JA, Søreide K, Tjensvoll K, Gilje B, Heikkilä R, Guriby M, Lothe RA, Smaaland R, Kørner H. Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients. Ann Surg Oncol 2012; 19: 3719-3726 [PMID: 22752373 DOI: 10.1245/ s10434-012-2454-8]
74. Noura S, Ohue M, Seki Y, Yamamoto T, Idota A, Fujii J, Yamasaki T, Nakajima H, Murata K, Kameyama M, Yamada T, Miyashiro I, Ohigashi H, Yano M, Ishikawa O, Imaoka S. Evaluation of the lateral sentinel node by indocyanine green for rectal cancer based on micrometastasis determined by reverse transcriptase-polymerase chain reaction. Oncol Rep 2008; 20: 745-750 [PMID: 18813813]
75. Merrie AE, Phillips LV, Yun K, McCall JL. Skip metastases in colon cancer: assessment by lymph node mapping using molecular detection. Surgery 2001; 129: 684-691 [PMID: 11391366]
76. Güller U, Zettl A, Worni M, Langer I, Cabalzar-Wondberg D, Viehl CT, Demartines N, Zuber M. Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging? Cancer 2012; 118: 6039-6045 [PMID: 22684906 DOI: 10.1002/cncr.27667]
77. Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ. Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 2007; 9: 563-571 [PMID: 17916603]
78. Tsouma A, Aggeli C, Pissimissis N, Lembessis P, Zografos GN, Koutsilieris M. Circulating tumor cells in colorectal cancer: detection methods and clinical significance. Anticancer Res 2008; 28: 3945-3960 [PMID: 19192655]
79. Gunn J, McCall JL, Yun K, Wright PA. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest 1996; 75: 611-616 [PMID: 8874391]